Real-time enrollment status for this systemic lupus erythematosus clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 3:23 PM UTC
| NCT Number | NCT07409181 |
| Recruiting Status | Recruiting |
| Condition | Systemic Lupus Erythematosus |
| Phase | PHASE2 |
| Target Enrollment | 405 participants |
| Active Locations | 30 sites in the US |
| Sponsor | Boehringer Ingelheim |
| Last Updated on CT.gov | October 1, 2026 (1 week ago) |
As of October 12, 2026: Clinical trial NCT07409181 is currently recruiting participants. This phase2 study for systemic lupus erythematosus is actively seeking new participants at 30 locations across the United States. The study is sponsored by Boehringer Ingelheim. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07409181 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 30 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07409181 was last updated 1 week ago (October 1, 2026). HelloStudys verifies this status automatically.